Cohort Study on Febrile Neutropenia in Adjuvant Chemotherapy for Breast Cancer Patients

Cohort Study on Febrile Neutropenia in Adjuvant Chemotherapy for Breast Cancer Patients - FN Study on Adjuvant Chemotherapy for Breast Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017857

Enrollment

1000

Registered

2015-06-15

Start date

2015-07-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Female patients with invasive ductal and lobular breast cancer 2. Stage I - III 3. Patients receiving (neo)adjuvant chemotherapy with risk of FN

Exclusion criteria

Exclusion criteria: Patients with no chemotherapy

Design outcomes

Primary

Measure	Time frame
Frequency of Febrile Neutropenia	—

Secondary

Measure	Time frame
1) FN in 1st. cycle 2)Grade 4 FN 3)Hospitalization 4) G-CSF 5)Antibiotics 6)Adverse events with FN and RDI 7) Patients with G-CSF 8) FN with or without G-CSF 9) Severe adverse events	—

Countries

Japan

Contacts

Public ContactHiroshi Kaise

Tokyo Medical University Breast Surgery

tishik55@gmail.com0333426111

Outcome results